Project Number 5U54NS065736-10 Agency/Funding Organization NINDS Funding Year 2018 View Full Project Details for Project 4: Synucleinopathy Biomarkers and the Skin Research Categorization Primary Disease / Condition Lewy Body Dementias CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 6. Emerging Biomarkers b. Proteomic Researcher and Organization Principal Investigator FREEMAN, ROY Principal Investigator First Name ROY Principal Investigator Last Name FREEMAN Awardee Organization VANDERBILT UNIVERSITY Awardee State Tennessee Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-15-019: LIMITED COMPETITION FOR THE CONTINUATION OF RARE DISEASES CLINICAL RESEARCH CONSORTIA IN THE RARE DISEASES CLINICAL RESEARCH NETWORK (U54) FY Overall Cost $252,643 Funding Organization Agency/Funding Organization NINDS Funding Organization Country United States Program Official SIEBER, BETH-ANNE Related Resources Clinical Trial Evaluating the Effectiveness of Intravenous Immunoglobulin Therapy in Autoimmune Autonomic Ganglionopathy Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
